ENVALITH
アトラグループ株式会社 logo

Artra Group Corporation

6029Standard MarketServices

アトラグループ株式会社 logo
Artra Group Corporation6029

Business

Artra Group Inc. operates under the corporate philosophy of "wanting to make people around the world healthy," running two segments: the A-COMS Business, a management support platform for acupuncture and osteopathic clinics, and the Toy Sales Business (Pelican Co., Ltd.). In the A-COMS Business, centered on its proprietary core system A-COMS, the company provides multi-layered services to acupuncture and osteopathic clinics, including medical expense billing agency services (Artra Billing Service), a retail and reservation platform (HONEY-STYLE), Equipment & Consumables Sales, a franchise chain (Honetsugi Chain), and Nursing Care Support (Honetsugi Day Service). Against the backdrop of structural industry changes such as declining medical expense reimbursements, the company aims to establish itself as infrastructure supporting the expansion of out-of-pocket treatments and enhanced retail sales.

Business Model

In the A-COMS Business, monthly membership revenue from the medical expense claim proxy service (Artra Billing Service) serves as a stable foundation, on top of which the company builds up franchise fees and monthly royalties (¥100 thousand per month) from the Honetsugi Chain, usage fees from clinics using HONEY-STYLE, Equipment & Consumables Sales, and financial income from A-COMS Finance (early cash conversion of medical expense claims). The Toy Sales Business consists of physical store sales operated by Pelican Co., Ltd. By adding services that leverage the scalability of A-COMS, the company aims to lock in customers and diversify revenue.

Company Strengths

The in-house developed core system for acupuncture and osteopathic clinics, A-COMS, centralizes treatment fee billing, patient management, business analysis, fraud prevention, and out-of-pocket treatment management. Sales of the Artra Billing Service increased 11.3% year on year to ¥605,739 million, with the acquisition of switchers from other companies' systems accelerating, making it highly difficult to replace as business infrastructure.

The company provides multiple services to the same customer base, including the Honetsugi Chain (sales of ¥522,741 million, up 8.3% year on year), HONEY-STYLE (sales of ¥99,066 million, up 29.0% year on year), equipment sales, nursing care support, and A-COMS Finance. Each service refers customers to and collaborates with the others, creating a structure that maximizes revenue per clinic.

In FY2025 (ending December 2025), operating profit was ¥140,812 million (up 2,377.6% year on year), and net income attributable to owners of parent turned positive at ¥258,292 million (versus a net loss of ¥36,736 million in the prior period). Total liabilities also decreased by ¥246,021 million year on year to ¥2,431,663 million, reflecting continued improvement in the company's financial structure.

ENVALITH's Perspective

The full-year FY2026 (ending December 2026) earnings forecast calls for net sales of ¥2,400 million (down 38.9% year on year) and operating profit of ¥120 million (down 14.8%), anticipating a substantial decline in revenue. This is thought to be mainly attributable to the loss of sales following the divestiture of the Toy Sales Business, but the focus is on whether standalone growth in the A-COMS Business can offset this scale of revenue decline. First-quarter net sales of ¥970 million represent 40.4% of the full-year forecast of ¥2,400 million, suggesting a sharp drop in the sales level from the second quarter onward once Pelican is excluded.

The first-quarter net loss attributable to owners of the parent of ¥113 million (loss per share of ¥11.08) was mainly attributable to a loss on sale of shares in affiliated companies of ¥130 million related to the sale of Pelican shares, and the company achieved a turnaround to profitability at both the operating and ordinary income levels. Investors need to distinguish between this one-time extraordinary loss and the company's recurring earnings power. The full-year net loss forecast of ¥25 million (loss per share of ¥2.44) suggests that the impact of the extraordinary loss is expected to be absorbed.

As an external factor, the declining trend in medical treatment fee reimbursement is an industry-wide challenge, and deteriorating management at clinics with high reliance on insurance carries the risk of leading to increased cancellations of A-COMS and sluggish equipment sales. On the other hand, the industry trend of expanding out-of-pocket treatment is a tailwind for the equipment sales and seminar businesses. In terms of market environment, the current state of adoption at only about 3,000 of approximately 50,000 clinics nationwide indicates substantial room for development in the remaining market, but maintaining differentiation from competing systems remains an ongoing challenge.

Growth Strategy

Strengthening its position as acupuncture and osteopathic clinic infrastructure through the enhancement of A-COMS functionality and expansion into adjacent markets

Accelerating new sign-ups from newly opened clinics and the acquisition of switch-over contracts from competitors' systems. In the first quarter of FY2026 (ending December 2026), Artra Billing Service grew 4.4% year-on-year and HONEY-STYLE grew 40.5% year-on-year, continuing high growth, with the stable subscription-based revenue base steadily expanding.

On March 31, 2026, the company transferred all shares of Pelican Co., Ltd., completing its selection and concentration strategy. By separating out the chronically loss-making segment, the structure has shifted so that the profitability of the A-COMS Business directly drives group performance. A loss on sale of affiliate shares of ¥130 million was recorded, but the structural reform has been completed.

Leveraging the scalability of the A-COMS platform, the company is promoting business expansion into the regenerative medicine, dentistry, relaxation, and beauty salon markets. It has stated its policy of accelerating the diversification of revenue opportunities by incorporating cutting-edge technologies, positioning itself as a "reverse aging" management support platform.

Against the backdrop of a declining trend in medical treatment expense reimbursements, the shift toward out-of-pocket (non-insurance) treatments has become an industry-wide challenge. The company continues to support clinic management through the expanded sale of equipment for out-of-pocket treatments and the holding of seminars. In the first quarter of FY2026 (ending December 2026), sales of Equipment & Consumables Sales decreased slightly by 2.6% year-on-year, but the company is focusing on expanding sales through sales activities and seminars.

Last updated: July 17, 2026